Is it time for 5-azacytidine combinations in high-risk myelodysplastic syndrome patients?

Author: Park Sophie  

Publisher: Informa Healthcare

ISSN: 1747-4086

Source: Expert Review of Hematology, Vol.6, Iss.1, 2013-02, pp. : 39-42

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content